Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTI-INSULIN ANTIBODY - ANVISA Registration 10337680036

Access comprehensive regulatory information for ANTI-INSULIN ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10337680036 and manufactured by RSR LTD.. The registration is held by GENESE PRODUTOS DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including MEDIPAN, ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10337680036
Registration Details
ANVISA Registration Number: 10337680036
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

TESTE PARA ANTICORPOS ANTI IA2
Risk Class II

Registration Details

10337680036

250000393259845

68384155000102

Company Information

RSR LTD.
United Kingdom
PT: REINO UNIDO

Dates and Status

May 06, 1999

VIGENTE

09/18/2025 19:00:01